Impact of Metabolic Bariatric Surgery on Weight Loss and Glycemic Control in Adults With Type 1 Diabetes: A Multicenter Retrospective Cohort Study
MBS was associated with substantial metabolic improvement in people with T1D and obesity, in particular in those with high HbA1c and insulin need at baseline.
Authors
- Jumana Al Kandari
- Bruno Dillemans (ORCID: https://orcid.org/0000-0001-8135-4844)
- Yves Van Nieuwenhove (ORCID: https://orcid.org/0000-0003-3064-5638)
- Matthias Lannoo (ORCID: https://orcid.org/0000-0001-7815-1157)
- Arianne van Bon
- Rieneke van der Meer (ORCID: https://orcid.org/0000-0002-5784-2060)
- Dr Ellen Deleus
- Jonathan Rosen (ORCID: https://orcid.org/0009-0001-4409-7110)
- Ronald S L Liem
- Ebaa Al Ozairi
- Mohammad Irshad
- Sofia Pazmino
- Eric Hazebroek
- Bart Van der Schueren
- Amar van Laar
- Carel W. le Roux
- Maarten Sluis
- Chantal Mathieu
- Roel Hoogma
- Nele Steenackers
- Carmen Hurtado del Pozo
- Luna Tolenaars
Institutions
- University College Dublin (IE)
- University of Ulster (GB)
- Ghent University Hospital (BE)
- Amiri Hospital (KW)
- Maastricht University (NL)
- Breakthrough (US)
- St. Antonius Ziekenhuis (NL)
- AZ Sint-Jan (BE)
- Nederlandse Obesitas Kliniek (NL)
- Groene Hart Ziekenhuis (NL)
- Amsterdam University Medical Centers (NL)
- Rijnstate Hospital (NL)
- Dasman Diabetes Institute (KW)
- University of Amsterdam (NL)
- Amsterdam UMC Location Vrije Universiteit Amsterdam (NL)
- KU Leuven (BE)
Publication Details
- Journal
- Diabetes Care
- Published
- 2026-02-18
- DOI
- https://doi.org/10.2337/dc25-2295
- Primary Topic
- Bariatric Surgery and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Eli Lilly and Company
- Sanofi
- European Federation of Pharmaceutical Industries and Associations
- Insulet Corporation
- European Commission
- KU Leuven
- Novo Nordisk
- European Association for the Study of Diabetes